Title:
COMPOSITION FOR PREVENTING OR TREATING CANCER OR INFLAMMATION COMPRISING NOVEL LEUCONOSTOC MESENTEROIDES STRAIN, AND METHOD FOR PREVENTING OR TREATING CANCER OR INFLAMMATION USING SAME
Document Type and Number:
WIPO Patent Application WO/2023/090903
Kind Code:
A1
Abstract:
The present application relates to a composition which is for preventing or treating cancer or inflammation and comprises a novel Leuconostoc mesenteroides strain, a culture thereof, or an ingredient derived therefrom.
Inventors:
MIN A RIM (KR)
KWON BO EUN (KR)
LEE JI YOUNG (KR)
KIM HYUN JEONG (KR)
PARK HYUN KYUNG (KR)
LEE SEUNGWON (KR)
KWON BO EUN (KR)
LEE JI YOUNG (KR)
KIM HYUN JEONG (KR)
PARK HYUN KYUNG (KR)
LEE SEUNGWON (KR)
Application Number:
PCT/KR2022/018223
Publication Date:
May 25, 2023
Filing Date:
November 17, 2022
Export Citation:
Assignee:
CJ BIOSCIENCE INC (KR)
International Classes:
A61K35/744; A23K10/18; A23L33/135; A61K45/06; A61P35/00
Domestic Patent References:
| WO2019169179A1 | 2019-09-06 |
Foreign References:
| KR20210112980A | 2021-09-15 | |||
| KR20160039095A | 2016-04-08 | |||
| KR101909999B1 | 2018-10-19 |
Other References:
FUJINO FUKUYO, NISHIO MISA, TSUDUKI MASAO, WATANABE TAKUMI, HATANAKA MIHO, HAYASHI KYOKO, KITADA YOSHIMI: "Immune system enhancement properties of a culture substance containing kudzu dextrin in the lactic acid bacteria Leuconostoc mesenteroides found in the kudzu vine", JAPANESE JOURNAL OF FOOD CHEMISTRY AND SAFETY, vol. 27, no. 1, 1 January 2020 (2020-01-01), pages 22 - 27, XP093068390
MIN ARIM, KWON BO-EUN, KIM HYUNJEONG, PARK HYUNKYUNG, LEE JIYOUNG, PYO KYOUNG-HO, CHO BYOUNG CHUL: "Abstract 3527: Novel bacteria strains, CJRS-10671 and CJRS-10672, enhance anti-tumor efficacy in LLC1 syngeneic model and humanized PDX mice model", CANCER RESEARCH, vol. 82, no. 12_Supplement, 15 June 2022 (2022-06-15), XP093068095, DOI: 10.1158/1538-7445.AM2022-3527
MIN ARIM, KWON BO-EUN, KIM HYUNJEONG, PARK HYUNKYUNG, LEE JIYOUNG, PYO KYOUNG-HO, CHO BYOUNG CHUL: "Abstract 3527: Novel bacteria strains, CJRS-10671 and CJRS-10672, enhance anti-tumor efficacy in LLC1 syngeneic model and humanized PDX mice model", CANCER RESEARCH, vol. 82, no. 12_Supplement, 15 June 2022 (2022-06-15), XP093068095, DOI: 10.1158/1538-7445.AM2022-3527
Attorney, Agent or Firm:
HANOL INTELLECTUAL PROPERTY AND LAW (KR)
Download PDF: